Articles selected from PubMed
Ma XJ, Wang Z, Ryan PD, Isakoff SJ, Barmettler A, Fuller A, Muir B, Mohapatra G, Salunga R, Tuggle JT, Tran Y, Tran D, Tassin A, Amon P, Wang W, Wang W, Enright E, Stecker K, Estepa-Sabal E, Smith B, Younger J, Balis U, Michaelson J, Bhan A, Habin K, Baer TM, Brugge J, Haber DA, Erlander MG, Sgroi DC: A two-gene expression ratio predicts clinical outcome in breast cancer patients treated with tamoxifen. [http:/ / www.ncbi.nlm.nih.gov/ entrez/ query.fcgi?cmd=Retrieve&db=pubmed&d opt=Abstract&list_uids=15193263] webcite
Cancer Cell 2004, 5: 607-616
Shou J, Massarweh S, Osborne CK, Wakeling AE, Ali S, Weiss H, Schiff R: Mechanisms of tamoxifen resistance: increased estrogen receptor-HER2/neu cross-talk in ER/HER2-positive breast cancer. [http:/ / www.ncbi.nlm.nih.gov/ entrez/ query.fcgi?cmd=Retrieve&db=pubmed&d opt=Abstract&list_uids=15199112] webcite
J Natl Cancer Inst 2004, 96: 926-935
Meng S, Tripathy D, Shete S, Ashfaq R, Haley B, Perkins S, Beitsch P, Khan A, Euhus D, Osborne C, Frenkel E, Hoover S, Leitch M, Clifford E, Vitetta E, Morrison L, Herlyn D, Terstappen LW, Fleming T, Fehm T, Tucker T, Lane N, Wang J, Uhr J: HER-2 gene amplification can be acquired as breast cancer progresses. [http:/ / www.ncbi.nlm.nih.gov/ entrez/ query.fcgi?cmd=Retrieve&db=pubmed&d opt=Abstract&list_uids=15194824] webcite
Proc Natl Acad Sci U S A 2004, 101: 9393-9398
Elkin M, Orgel A, Kleinman HK: An angiogenic switch in breast cancer involves estrogen and soluble vascular endothelial growth factor receptor 1. [http:/ / www.ncbi.nlm.nih.gov/ entrez/ query.fcgi?cmd=Retrieve&db=pubmed&d opt=Abstract&list_uids=15173272] webcite
J Natl Cancer Inst 2004, 96: 875-878
Arteaga CL, Baselga J: Tyrosine kinase inhibitors: why does the current process of clinical development not apply to them? [http:/ / www.ncbi.nlm.nih.gov/ entrez/ query.fcgi?cmd=Retrieve&db=pubmed&d opt=Abstract&list_uids=15193255] webcite
Cancer Cell 2004, 5: 525-531
Clayton H, Titley I, Vivanco Md M: Growth and differentiation of progenitor/stem cells derived from the human mammary gland. [http:/ / www.ncbi.nlm.nih.gov/ entrez/ query.fcgi?cmd=Retrieve&db=pubmed&d opt=Abstract&list_uids=15212947] webcite
Exp Cell Res 2004, 297: 444-460
Ueda Y, Wang S, Dumont N, Yi JY, Koh Y, Arteaga CL: Overexpression of HER2 (erbB2) in human breast epithelial cells unmasks transforming growth factor beta-induced cell motility. [http:/ / www.ncbi.nlm.nih.gov/ entrez/ query.fcgi?cmd=Retrieve&db=pubmed&d opt=Abstract&list_uids=15044465] webcite
J Biol Chem 2004, 279: 24505-24513
